Hollsteen
← Zoom

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2017: −$29.0M · 10-K 0001585521-20-000095 filed Mar 20, 2020Equity incl. NCI · Q1 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2018: −$27.0M · 10-K 0001585521-20-000095 filed Mar 20, 2020Equity incl. NCI · Q1 FY2019: −$27.0M · 10-Q 0001564590-19-022032 filed Jun 7, 2019Equity incl. NCI · Q2 FY2019: −$21.0M · 10-Q 0001585521-19-000020 filed Sep 13, 2019Equity incl. NCI · Q3 FY2019: −$19.0M · 10-Q 0001585521-19-000059 filed Dec 9, 2019Equity incl. NCI · Q4 FY2019: −$7.0M · 10-K 0001585521-20-000095 filed Mar 20, 2020Equity incl. NCI · Q1 FY2020: $720M · 10-Q 0001564590-19-022032 filed Jun 7, 2019Equity incl. NCI · Q2 FY2020: $744M · 10-Q 0001585521-19-000020 filed Sep 13, 2019Equity incl. NCI · Q3 FY2020: $773M · 10-Q 0001585521-19-000059 filed Dec 9, 2019Equity incl. NCI · Q4 FY2020: $834M · 10-K 0001585521-20-000095 filed Mar 20, 2020Equity incl. NCI · Q1 FY2021: $902M · 10-Q 0001585521-20-000154 filed Jun 5, 2020Equity incl. NCI · Q2 FY2021: $1.2B · 10-Q 0001585521-20-000238 filed Sep 3, 2020Equity incl. NCI · Q3 FY2021: $1.5B · 10-Q 0001585521-20-000299 filed Dec 4, 2020Equity incl. NCI · Q4 FY2021: $3.9B · 10-K 0001585521-21-000048 filed Mar 18, 2021Equity incl. NCI · Q1 FY2022: $4.2B · 10-Q 0001585521-21-000131 filed Jun 2, 2021Equity incl. NCI · Q2 FY2022: $4.7B · 10-Q 0001585521-21-000235 filed Aug 31, 2021Equity incl. NCI · Q3 FY2022: $5.1B · 10-Q 0001585521-21-000295 filed Nov 23, 2021Equity incl. NCI · Q4 FY2022: $5.8B · 10-K 0001585521-22-000037 filed Mar 7, 2022Equity incl. NCI · Q1 FY2023: $5.9B · 10-Q 0001585521-22-000106 filed May 25, 2022Equity incl. NCI · Q2 FY2023: $6.0B · 10-Q 0001585521-22-000180 filed Aug 24, 2022Equity incl. NCI · Q3 FY2023: $5.8B · 10-Q 0001585521-22-000213 filed Nov 23, 2022Equity incl. NCI · Q4 FY2023: $6.2B · 10-K 0001585521-23-000035 filed Mar 3, 2023Equity incl. NCI · Q1 FY2024: $6.5B · 10-Q 0001585521-23-000128 filed May 25, 2023Equity incl. NCI · Q2 FY2024: $7.0B · 10-Q 0001585521-23-000194 filed Aug 23, 2023Equity incl. NCI · Q3 FY2024: $7.4B · 10-Q 0001585521-23-000249 filed Nov 21, 2023Equity incl. NCI · Q4 FY2024: $8.0B · 10-K 0001585521-24-000030 filed Mar 4, 2024Equity incl. NCI · Q1 FY2025: $8.3B · 10-Q 0001585521-24-000094 filed May 22, 2024Equity incl. NCI · Q2 FY2025: $8.5B · 10-Q 0001585521-24-000181 filed Aug 23, 2024Equity incl. NCI · Q3 FY2025: $8.7B · 10-Q 0001585521-24-000260 filed Nov 26, 2024Equity incl. NCI · Q4 FY2025: $8.9B · 10-K 0001585521-25-000042 filed Feb 28, 2025Equity incl. NCI · Q1 FY2026: $8.9B · 10-Q 0001585521-25-000090 filed May 23, 2025Equity incl. NCI · Q2 FY2026: $8.9B · 10-Q 0001585521-25-000141 filed Aug 22, 2025Equity incl. NCI · Q3 FY2026: $9.3B · 10-Q 0001585521-25-000202 filed Nov 25, 2025Equity incl. NCI · Q4 FY2026: $9.8B · 10-K 0001585521-26-000030 filed Feb 27, 2026Equity incl. NCI · Q1 FY2027: $10.0B · 10-Q 0001585521-26-000071 filed May 22, 2026Equity incl. NCI · Q2 FY2027: $11.3B · 10-Q 0001585521-26-000121 filed Aug 26, 2026missing8.711.30.0Q1 FY2016Q2 FY2027Q3 FY2025
$BEquity incl. NCI · Q3 FY2025: $8.7B · 10-Q 0001585521-24-000260 filed Nov 26, 2024Equity incl. NCI · Q4 FY2025: $8.9B · 10-K 0001585521-25-000042 filed Feb 28, 2025Equity incl. NCI · Q1 FY2026: $8.9B · 10-Q 0001585521-25-000090 filed May 23, 2025Equity incl. NCI · Q2 FY2026: $8.9B · 10-Q 0001585521-25-000141 filed Aug 22, 2025Equity incl. NCI · Q3 FY2026: $9.3B · 10-Q 0001585521-25-000202 filed Nov 25, 2025Equity incl. NCI · Q4 FY2026: $9.8B · 10-K 0001585521-26-000030 filed Feb 27, 2026Equity incl. NCI · Q1 FY2027: $10.0B · 10-Q 0001585521-26-000071 filed May 22, 2026Equity incl. NCI · Q2 FY2027: $11.3B · 10-Q 0001585521-26-000121 filed Aug 26, 20268.711.3Q3 FY2025Q2 FY2027Q3 FY2026
Q3 FY2025
8.7$B
All values (36)
PeriodValue ($B)Status
Q2 FY202711.3reported
Q1 FY202710.0reported
Q4 FY20269.8reported
Q3 FY20269.3reported
Q2 FY20269.0reported
Q1 FY20268.9reported
Q4 FY20258.9reported
Q3 FY20258.7reported
Q2 FY20258.5reported
Q1 FY20258.3reported
Q4 FY20248.0reported
Q3 FY20247.4reported
Q2 FY20247.0reported
Q1 FY20246.5reported
Q4 FY20236.2reported
Q3 FY20235.8reported
Q2 FY20236.0reported
Q1 FY20235.9reported
Q4 FY20225.8reported
Q3 FY20225.1reported
Q2 FY20224.7reported
Q1 FY20224.2reported
Q4 FY20213.9reported
Q3 FY20211.5reported
Q2 FY20211.2reported
Q1 FY20210.9reported
Q4 FY20200.8reported
Q3 FY20200.8reported
Q2 FY20200.7reported
Q1 FY20200.7reported
Q4 FY20190.0reported
Q3 FY20190.0reported
Q2 FY20190.0reported
Q1 FY20190.0reported
Q4 FY20180.0reported
Q1 FY2018 – Q3 FY2018–missing (3 periods): No verified SEC value extracted, although the company reports this metric in other periods.
Q4 FY2017Noneerror
Q1 FY2016 – Q3 FY2017–missing (7 periods): Grund wie bei Q1 FY2018 – Q3 FY2018.

Show reported periods only · CSV with all sources · Technical ID: equity_total

More metrics for Zoom

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$8.7B
Period
Q3 FY2025, ended Oct 31, 2024 · as of Oct 31, 2024 (balance as of date, not a sum)
Source
10-Q, filed Nov 26, 2024 · 0001585521-24-000260
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$8.7BNov 26, 202410-Q 0001585521-24-000260reported · confidence 1. · current